Roswell Park Leukemia Chief Shares Promising Findings on New Treatment...

Dr. Eunice Wang presents results of early-phase studies of investigational targeted treatments for AML; novel menin-KMT2A inhibitor appears to be safe and well-tolerated, and FLT3 inhibitor plus...(PRWeb December 05, 2020)Read the full story at https://www.prweb.com/releases/roswell_park_leukemia_chief_shares_promising_findings_on_new_treatment_options_at_ash_2020/prweb17593179.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news